Higher expression of Rad51 by a factor of about 2 and a high fraction of Rad51 foci in proliferating (>40%), in comparison to G1-enriched, confluent populations (<5%) was also found in NSCLC cell lines, irrespective of the p53 status. The gene discussed is TP53; the disease is non-small cell lung carcinoma.